The oncogene *BCR--ABL1* hijacks a B cell signaling protein by inducing the synthesis of a linker protein, according to Feldhahn and colleagues on page 1837. This study helps explain how BCR--ABL1 causes B cell leukemias in humans and identifies a potential new target for drug development.

FigureThe oncogene BCR--ABL1 induces the synthesis of a splice variant of Bruton\'s tyrosine kinase (BTK^p52^) that hijacks full-length BTK and transforms B cells.

Translocation events that combine unrelated chromosomal sequences are found in up to 65% of human acute leukemias. One such translocation event creates a chimeric protein between the signaling protein BCR and the tyrosine kinase ABL1. The BCR--ABL1 fusion allows precursor B cells to bypass survival signals from the pre-B cell receptor that are normally required for B cell survival. But exactly how BCR--ABL1 ensures B cell survival in the absence of pre-B cell receptor signals was not completely clear.

Feldhahn et al. now show that Bruton\'s tyrosine kinase (BTK)---a key component of the pre-B cell receptor signaling pathway---is perpetually phosphorylated (and thus activated) in BCR--ABL1-expressing leukemia cells. Downstream signals, including calcium flux and expression of the pro-survival protein Bcl-xL, were also activated in these cells. BTK phosphorylation depended on the kinase activity of BCR--ABL1, as inhibiting this kinase decreased BTK phosphorylation. But the mechanism was mysterious, as previous studies had ruled out a direct interaction between BCR--ABL1 and BTK.

The authors had noted that several kinase-deficient splice variants of BTK accumulated in leukemia cells. One of these variants (BTK^p52^) bound to both BCL--ABL1 and full-length BTK, providing a bridge that allowed BCR--ABL1 to phosphorylate full-length BTK. BTK^p52^ was needed to maintain cell survival, as removal of this protein drove the cells into apoptosis. Remarkably, the BCR--ABL1 protein itself triggered the production of the BTK splice variants, a finding consistent with previous studies showing that BCR--ABL1 induces the expression of proteins involved in RNA splicing.
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